Alere Inc  

(Public, NYSE:ALR)   Watch this stock  
Find more results for Alere Toxicology Services, Inc.�
+0.98 (2.38%)
Real-time:   3:23PM EST
NYSE real-time data - Disclaimer
Currency in USD
Range 41.24 - 42.18
52 week 35.81 - 55.99
Open 41.25
Vol / Avg. 416,873.00/882,516.00
Mkt cap 3.57B
P/E     -
Div/yield     -
EPS -0.42
Shares 86.26M
Beta 1.66
Inst. own 101%
Feb 8, 2016
Q4 2015 Alere Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Nov 4, 2015
Q3 2015 Alere Inc Earnings Call
Nov 4, 2015
Q3 2015 Alere Inc Earnings Release
Sep 16, 2015
Alere Inc at Morgan Stanley Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 0.08% -7.48%
Operating margin 4.84% 3.81%
EBITD margin - 11.14%
Return on average assets 0.03% -2.82%
Return on average equity 0.05% -14.27%
Employees 9,800 -
CDP Score - -


51 Sawyer Rd Ste 200
WALTHAM, MA 02453-3448
United States - Map
+1-781-6473900 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Alere Inc. is a provider of health information through diagnostic tests. The Company operates through professional diagnostics, patient self-testing, consumer diagnostics and, corporate and other segments. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The patient-self testing segment provides services designed to provide physicians with actionable data that allow them to make decisions in real time, deliver care, and put the individuals they treat on a pathway to better health. The consumer diagnostics segment consists primarily of manufacturing operations related to its role as the exclusive manufacturer of products for SPD Swiss Precision Diagnostics (SPD), its 50/50 joint venture with The Procter & Gamble Company (P&G).

Officers and directors

Gregg J. Powers Independent Chairman of the Board
Age: 52
Bio & Compensation  - Reuters
Namal Nawana President, Chief Executive Officer, Director
Age: 44
Bio & Compensation  - Reuters
James F. Hinrichs Chief Financial Officer, Executive Vice President
Age: 47
Bio & Compensation  - Reuters
Daniella Cramp Global President - Cardiometabolic Business Unit
Age: 41
Bio & Compensation  - Reuters
Sanjay Malkani Global President - Toxicology
Age: 45
Bio & Compensation  - Reuters
Avi Pelossof Global President - Infectious Disease Business Unit
Age: 52
Bio & Compensation  - Reuters
Ellen Chiniara Senior Vice President, General Counsel, Chief Ethics and Compliance Officer and Secretary
Age: 56
Bio & Compensation  - Reuters
John Bridgen Ph.D. Senior Vice President - Business Development
Age: 68
Bio & Compensation  - Reuters
Mark Gladwell Senior Vice President - Global Operations
Age: 40
Bio & Compensation  - Reuters
Melissa Guerdan Senior Vice President - Global Quality and Regulatory Assurance
Age: 41
Bio & Compensation  - Reuters